{"_id": "36144268|None", "id": "36144268", "infons": {}, "passages": [{"infons": {"journal": "Metabolites. 2022 Sep 14;12(9):864. doi: 10.3390/metabo12090864.", "year": "2022", "article-id_pmc": "PMC9503806", "type": "title", "authors": "Lanznaster D, Dingeo G, Samey RA, Emond P, Blasco H"}, "offset": 0, "text": "Metabolomics as a Crucial Tool to Develop New Therapeutic Strategies for Neurodegenerative Diseases.", "sentences": [], "annotations": [{"id": "1", "infons": {"identifier": "MESH:D019636", "type": "Disease", "valid": true, "normalized": ["D019636"], "database": "ncbi_mesh", "normalized_id": "D019636", "biotype": "disease", "name": "Neurodegenerative Diseases", "accession": "@DISEASE_Neurodegenerative_Diseases"}, "text": "Neurodegenerative Diseases", "locations": [{"offset": 73, "length": 26}]}], "relations": []}, {"infons": {"type": "abstract"}, "offset": 101, "text": "Neurodegenerative diseases (NDs), such as Alzheimer's (AD), Parkinson's (PD), and amyotrophic lateral sclerosis (ALS), share common pathological mechanisms, including metabolism alterations. However, their specific neuronal cell types affected and molecular biomarkers suggest that there are both common and specific alterations regarding metabolite levels. In this review, we were interested in identifying metabolite alterations that have been reported in preclinical models of NDs and that have also been documented as altered in NDs patients. Such alterations could represent interesting targets for the development of targeted therapy. Importantly, the translation of such findings from preclinical to clinical studies is primordial for the study of possible therapeutic agents. We found that N-acetyl-aspartate (NAA), myo-inositol, and glutamate are commonly altered in the three NDs investigated here. We also found other metabolites commonly altered in both AD and PD. In this review, we discuss the studies reporting such alterations and the possible pathological mechanism underlying them. Finally, we discuss clinical trials that have attempted to develop treatments targeting such alterations. We conclude that the treatment combination of both common and differential alterations would increase the chances of patients having access to efficient treatments for each ND.", "sentences": [], "annotations": [{"id": "22", "infons": {"identifier": "MESH:D019636", "type": "Disease", "valid": true, "normalized": ["D019636"], "database": "ncbi_mesh", "normalized_id": "D019636", "biotype": "disease", "name": "Neurodegenerative Diseases", "accession": "@DISEASE_Neurodegenerative_Diseases"}, "text": "Neurodegenerative diseases", "locations": [{"offset": 101, "length": 26}]}, {"id": "23", "infons": {"identifier": "MESH:D019636", "type": "Disease", "valid": true, "normalized": ["D019636"], "database": "ncbi_mesh", "normalized_id": "D019636", "biotype": "disease", "name": "Neurodegenerative Diseases", "accession": "@DISEASE_Neurodegenerative_Diseases"}, "text": "NDs", "locations": [{"offset": 129, "length": 3}]}, {"id": "24", "infons": {"identifier": "MESH:D000544", "type": "Disease", "valid": true, "normalized": ["D000544"], "database": "ncbi_mesh", "normalized_id": "D000544", "biotype": "disease", "name": "Alzheimer Disease", "accession": "@DISEASE_Alzheimer_Disease"}, "text": "Alzheimer's", "locations": [{"offset": 143, "length": 11}]}, {"id": "25", "infons": {"identifier": "MESH:D000544", "type": "Disease", "valid": true, "normalized": ["D000544"], "database": "ncbi_mesh", "normalized_id": "D000544", "biotype": "disease", "name": "Alzheimer Disease", "accession": "@DISEASE_Alzheimer_Disease"}, "text": "AD", "locations": [{"offset": 156, "length": 2}]}, {"id": "26", "infons": {"identifier": "MESH:D010300", "type": "Disease", "valid": true, "normalized": ["D010300"], "database": "ncbi_mesh", "normalized_id": "D010300", "biotype": "disease", "name": "Parkinson Disease", "accession": "@DISEASE_Parkinson_Disease"}, "text": "Parkinson's", "locations": [{"offset": 161, "length": 11}]}, {"id": "27", "infons": {"identifier": "MESH:D010300", "type": "Disease", "valid": true, "normalized": ["D010300"], "database": "ncbi_mesh", "normalized_id": "D010300", "biotype": "disease", "name": "Parkinson Disease", "accession": "@DISEASE_Parkinson_Disease"}, "text": "PD", "locations": [{"offset": 174, "length": 2}]}, {"id": "28", "infons": {"identifier": "MESH:D000690", "type": "Disease", "valid": true, "normalized": ["D000690"], "database": "ncbi_mesh", "normalized_id": "D000690", "biotype": "disease", "name": "Amyotrophic Lateral Sclerosis", "accession": "@DISEASE_Amyotrophic_Lateral_Sclerosis"}, "text": "amyotrophic lateral sclerosis", "locations": [{"offset": 183, "length": 29}]}, {"id": "29", "infons": {"identifier": "MESH:D000690", "type": "Disease", "valid": true, "normalized": ["D000690"], "database": "ncbi_mesh", "normalized_id": "D000690", "biotype": "disease", "name": "Amyotrophic Lateral Sclerosis", "accession": "@DISEASE_Amyotrophic_Lateral_Sclerosis"}, "text": "ALS", "locations": [{"offset": 214, "length": 3}]}, {"id": "30", "infons": {"identifier": "MESH:D019636", "type": "Disease", "valid": true, "normalized": ["D019636"], "database": "ncbi_mesh", "normalized_id": "D019636", "biotype": "disease", "name": "Neurodegenerative Diseases", "accession": "@DISEASE_Neurodegenerative_Diseases"}, "text": "NDs", "locations": [{"offset": 581, "length": 3}]}, {"id": "31", "infons": {"identifier": "MESH:D019636", "type": "Disease", "valid": true, "normalized": ["D019636"], "database": "ncbi_mesh", "normalized_id": "D019636", "biotype": "disease", "name": "Neurodegenerative Diseases", "accession": "@DISEASE_Neurodegenerative_Diseases"}, "text": "NDs", "locations": [{"offset": 634, "length": 3}]}, {"id": "32", "infons": {"identifier": "9606", "type": "Species", "valid": true, "normalized": [9606], "database": "ncbi_taxonomy", "normalized_id": 9606, "biotype": "species", "name": "9606", "accession": null}, "text": "patients", "locations": [{"offset": 638, "length": 8}]}, {"id": "33", "infons": {"identifier": "MESH:C000179", "type": "Chemical", "valid": true, "normalized": ["C000179"], "database": "ncbi_mesh", "normalized_id": "C000179", "biotype": "chemical", "name": "N-acetylaspartate", "accession": "@CHEMICAL_N_acetylaspartate"}, "text": "N-acetyl-aspartate", "locations": [{"offset": 899, "length": 18}]}, {"id": "34", "infons": {"identifier": "MESH:C000179", "type": "Chemical", "valid": true, "normalized": ["C000179"], "database": "ncbi_mesh", "normalized_id": "C000179", "biotype": "chemical", "name": "N-acetylaspartate", "accession": "@CHEMICAL_N_acetylaspartate"}, "text": "NAA", "locations": [{"offset": 919, "length": 3}]}, {"id": "35", "infons": {"identifier": "MESH:D007294", "type": "Chemical", "valid": true, "normalized": ["D007294"], "database": "ncbi_mesh", "normalized_id": "D007294", "biotype": "chemical", "name": "Inositol", "accession": "@CHEMICAL_Inositol"}, "text": "myo-inositol", "locations": [{"offset": 925, "length": 12}]}, {"id": "36", "infons": {"identifier": "MESH:D018698", "type": "Chemical", "valid": true, "normalized": ["D018698"], "database": "ncbi_mesh", "normalized_id": "D018698", "biotype": "chemical", "name": "Glutamic Acid", "accession": "@CHEMICAL_Glutamic_Acid"}, "text": "glutamate", "locations": [{"offset": 943, "length": 9}]}, {"id": "37", "infons": {"identifier": "MESH:D019636", "type": "Disease", "valid": true, "normalized": ["D019636"], "database": "ncbi_mesh", "normalized_id": "D019636", "biotype": "disease", "name": "Neurodegenerative Diseases", "accession": "@DISEASE_Neurodegenerative_Diseases"}, "text": "NDs", "locations": [{"offset": 987, "length": 3}]}, {"id": "38", "infons": {"identifier": "MESH:D000544", "type": "Disease", "valid": true, "normalized": ["D000544"], "database": "ncbi_mesh", "normalized_id": "D000544", "biotype": "disease", "name": "Alzheimer Disease", "accession": "@DISEASE_Alzheimer_Disease"}, "text": "AD", "locations": [{"offset": 1067, "length": 2}]}, {"id": "39", "infons": {"identifier": "MESH:D010300", "type": "Disease", "valid": true, "normalized": ["D010300"], "database": "ncbi_mesh", "normalized_id": "D010300", "biotype": "disease", "name": "Parkinson Disease", "accession": "@DISEASE_Parkinson_Disease"}, "text": "PD", "locations": [{"offset": 1074, "length": 2}]}, {"id": "40", "infons": {"identifier": "9606", "type": "Species", "valid": true, "normalized": [9606], "database": "ncbi_taxonomy", "normalized_id": 9606, "biotype": "species", "name": "9606", "accession": null}, "text": "patients", "locations": [{"offset": 1424, "length": 8}]}, {"id": "41", "infons": {"identifier": "MESH:C537849", "type": "Disease", "valid": true, "normalized": ["C537849"], "database": "ncbi_mesh", "normalized_id": "C537849", "biotype": "disease", "name": "Norrie disease", "accession": "@DISEASE_Norrie_disease"}, "text": "ND", "locations": [{"offset": 1480, "length": 2}]}], "relations": []}], "relations": [{"id": "R1", "infons": {"score": "0.9985", "role1": {"identifier": "MESH:D007294", "type": "Chemical", "valid": true, "normalized": ["D007294"], "database": "ncbi_mesh", "normalized_id": "D007294", "biotype": "chemical", "name": "Inositol", "accession": "@CHEMICAL_Inositol"}, "role2": {"identifier": "MESH:D019636", "type": "Disease", "valid": true, "normalized": ["D019636"], "database": "ncbi_mesh", "normalized_id": "D019636", "biotype": "disease", "name": "Neurodegenerative Diseases", "accession": "@DISEASE_Neurodegenerative_Diseases"}, "type": "Association"}, "nodes": [{"refid": "0", "role": "14,16"}]}, {"id": "R2", "infons": {"score": "0.9988", "role1": {"identifier": "MESH:D018698", "type": "Chemical", "valid": true, "normalized": ["D018698"], "database": "ncbi_mesh", "normalized_id": "D018698", "biotype": "chemical", "name": "Glutamic Acid", "accession": "@CHEMICAL_Glutamic_Acid"}, "role2": {"identifier": "MESH:D019636", "type": "Disease", "valid": true, "normalized": ["D019636"], "database": "ncbi_mesh", "normalized_id": "D019636", "biotype": "disease", "name": "Neurodegenerative Diseases", "accession": "@DISEASE_Neurodegenerative_Diseases"}, "type": "Association"}, "nodes": [{"refid": "1", "role": "15,16"}]}, {"id": "R3", "infons": {"score": "0.9991", "role1": {"identifier": "MESH:C000179", "type": "Chemical", "valid": true, "normalized": ["C000179"], "database": "ncbi_mesh", "normalized_id": "C000179", "biotype": "chemical", "name": "N-acetylaspartate", "accession": "@CHEMICAL_N_acetylaspartate"}, "role2": {"identifier": "MESH:D019636", "type": "Disease", "valid": true, "normalized": ["D019636"], "database": "ncbi_mesh", "normalized_id": "D019636", "biotype": "disease", "name": "Neurodegenerative Diseases", "accession": "@DISEASE_Neurodegenerative_Diseases"}, "type": "Association"}, "nodes": [{"refid": "2", "role": "12,16"}]}], "pmid": 36144268, "pmcid": null, "meta": {}, "date": "2022-09-14T00:00:00Z", "journal": "Metabolites", "authors": ["Lanznaster D", "Dingeo G", "Samey RA", "Emond P", "Blasco H"], "relations_display": [{"name": "associate|@CHEMICAL_Inositol|@DISEASE_Neurodegenerative_Diseases"}, {"name": "associate|@CHEMICAL_Glutamic_Acid|@DISEASE_Neurodegenerative_Diseases"}, {"name": "associate|@CHEMICAL_N_acetylaspartate|@DISEASE_Neurodegenerative_Diseases"}]}
